09Oct
Caremark Round II: Beware Red Flags in Drug Development
On October 1, 2019, the Delaware Court of Chancery applied the Delaware Supreme Court’s recent decision on Caremark board oversight claims in the context of operating in a highly regulated industry to allow derivative claims to proceed against the...
By:
Goodwin
Related
A Federal District Court in New York recently fielded the issue of whether there is such a thing as ...
Read More >
Day 2 of the 2019 ILG National Conference in Milwaukee started with a favorite guest – EEOC Commiss...
Read More >
The Situation: The Netherlands has 79 bilateral investment treaties ("BITs") in place with non-EU co...
Read More >
Recently, we have addressed the evolving regulatory landscape for per- and poly-fluoroalkyl substanc...
Read More >
A federal appeals court ruled yesterday that the 2012 guidance document from the Equal Employment Op...
Read More >
Union employees are not permitted to delay designation of FMLA time while they use job-protected acc...
Read More >